Skip to content

Clinical study of Chinese medicine combined with acupoint catgut embedding in treatment of obesity polycystic ovary syndrome

Clinical study of Chinese medicine combined with acupoint catgut embedding in treatment of obesity polycystic ovary syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000057
Enrollment
Unknown
Registered
2022-06-16
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic ovary syndrome

Interventions

Acupuncture drug group:Decoction combined with Acupoint Catgut Embedding

Sponsors

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (l) It meets the two diagnostic criteria of polycystic ovary syndrome and obesity in western medicine. (2) It conforms to the syndrome differentiation of traditional Chinese medicine and belongs to the syndrome type of kidney deficiency, liver heat, phlegm and blood stasis. (3) Between the ages of 18 and 40. (4) Volunteer subjects who can persist in treatment for 6 months.

Exclusion criteria

Exclusion criteria: (l) Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, psychosis. (2) Other diseases that cause abnormal ovulation (Cushing's syndrome, atypical congenital adrenal hyperplasia, ovarian or adrenal tumors, functional hypothalamic amenorrhea, thyroid disease, hyperprolactinemia and early-onset ovarian insufficiency). (3) Those who use hormonal and metabolic drugs at the same time to affect the result judgment. (4) Those who are allergic to the study drug and cannot accept acupuncture stimulation.

Design outcomes

Primary

MeasureTime frame
WHR;TCM symptoms;triglyceride;total cholesterol;Ovulation;BMI;Liver and kidney function;Low density lipoprotein;Menstrual condition;Ovarian condition;tongue and pulse pictures;Six items of sex hormones;

Countries

China

Contacts

Public ContactWangDonghong
wdh93@sina.com13301018275

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026